Literature DB >> 23276610

[Multidisciplinary guidelines for the management of community-acquired pneumonia].

Antoni Torres, José Barberán, Miquel Falguera, Rosario Menéndez, Jesús Molina, Pedro Olaechea, Alejandro Rodríguez.   

Abstract

Community-acquired pneumonia (CAP) is an infectious respiratory disease with an incidence that ranges from 3 to 8 cases per 1,000 inhabitants per year. This incidence increases with age and comorbidities. Forty per cent of CAP patients require hospitalization and around 10% of these patients are admitted in an Intensive Care Unit (ICU). Several studies have suggested that the implementation of clinical guidelines has a positive impact in the outcome of patients including mortality and length of stay. The more recent and used guidelines are those from Infectious Diseases Society of America/American Thoracic Society, published in 2007, the 2009 from the British Thoracic Society, and that from the European Respiratory Society/European Society of Clinical Microbiology and Infectious Diseases, published in 2010. In Spain, the most recently released guideline is the Sociedad Española de Neumología y Cirugía Torácica-2011 guideline. The present guidelines GNAC are designed to be used by the majority of health-care professionals that can participate in the care of CAP patients including diagnosis, decision of hospital and ICU admission, treatment and prevention. The Centro Cochrane Iberoamericano (CCIB) has participated in summarizing the previous guidelines and in the bibliography search. For each one of the following sections the panel of experts has developed a table with recommendations classified according to its evidence, strength and practical applicability using the Grading of Recommendations of Assessment Development and Evaluations (GRADE) system: 1. Epidemiology, microbiological etiology and antibiotic resistances.2. Clinical and microbiological diagnosis.3. Prognostic scales and decision of hospital admission.4. ICU admission criteria. 5. Empirical and definitive antibiotic treatment.6. Treatment failure. 7. Prevention.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23276610     DOI: 10.1016/j.medcli.2012.09.034

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  16 in total

Review 1.  Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART.

Authors:  Catia Cillóniz; Antonella Ielpo; Antoni Torres
Journal:  Curr Infect Dis Rep       Date:  2018-09-10       Impact factor: 3.725

2.  Adaptation of antibiotic treatment to clinical practice guidelines in patients aged ⩾65 years hospitalised due to community-acquired pneumonia.

Authors:  M A Fernandez-Sierra; M T Rueda-Domingo; M M Rodriguez-Del-Aguila; M J Perez-Lozano; L Force; T Fernandez-Villa; J Astray; M Egurrola; J Castilla; F Sanz; D Toledo; A Dominguez
Journal:  Epidemiol Infect       Date:  2018-08-02       Impact factor: 4.434

Review 3.  Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients.

Authors:  Jesús López-Alcalde; Ricardo Rodriguez-Barrientos; Jesús Redondo-Sánchez; Javier Muñoz-Gutiérrez; José María Molero García; Carmen Rodríguez-Fernández; Julio Heras-Mosteiro; Jaime Marin-Cañada; Jose Casanova-Colominas; Amaya Azcoaga-Lorenzo; Virginia Hernandez Santiago; Manuel Gómez-García
Journal:  Cochrane Database Syst Rev       Date:  2018-09-06

4.  Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality.

Authors:  Jesus F Bermejo-Martin; Catia Cilloniz; Raul Mendez; Raquel Almansa; Albert Gabarrus; Adrian Ceccato; Antoni Torres; Rosario Menendez
Journal:  EBioMedicine       Date:  2017-09-21       Impact factor: 8.143

5.  Efficacy of high doses of oral penicillin versus amoxicillin in the treatment of adults with non-severe pneumonia attended in the community: study protocol for a randomised controlled trial.

Authors:  Carl Llor; Javier Arranz; Rosa Morros; Anna García-Sangenís; Helena Pera; Joan Llobera; Mireia Guillén-Solà; Eugenia Carandell; Jesús Ortega; Silvia Hernández; Marc Miravitlles
Journal:  BMC Fam Pract       Date:  2013-04-17       Impact factor: 2.497

Review 6.  The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.

Authors:  A Torres; F Blasi; W E Peetermans; G Viegi; T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-15       Impact factor: 3.267

7.  [Consensus guidelines for the management of community acquired pneumonia in the elderly patient].

Authors:  Juan González Del Castillo; Francisco Javier Martín-Sánchez; Pedro Llinares; Rosario Menéndez; Abel Mujal; Enrique Navas; José Barberán
Journal:  Rev Esp Geriatr Gerontol       Date:  2014-05-27

8.  [Infections in critically ill patients].

Authors:  M J Asensio Martín; M Hernández Bernal; S Yus Teruel; A Minvielle
Journal:  Medicine (Madr)       Date:  2018-03-19

9.  [Thoughts on the epidemiology of community acquired pneumonia].

Authors:  Agustín Julián-Jiménez; Raquel Parejo-Miguez; Natividad Laín-Terés; María José Palomo de Los Reyes
Journal:  Aten Primaria       Date:  2013-12-21       Impact factor: 1.137

10.  Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis.

Authors:  Catia Cilloniz; Héctor José Peroni; Albert Gabarrús; Carolina García-Vidal; Juan M Pericàs; Jesús Bermejo-Martin; Antoni Torres
Journal:  Open Forum Infect Dis       Date:  2021-04-02       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.